Evaluation of Left Ventricular Function to Predict Weaning Success in the Intensive Care Unit

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKanuni Sultan Suleyman Training and Research Hospital

About this trial

The goal of this prospective observational study is to evaluate whether left ventricular function parameters assessed via transthoracic echocardiography (TTE) can predict weaning success from mechanical ventilation in adult intensive care unit (ICU) patients. The main questions it aims to answer are:

Can the Left Ventricular Outflow Tract Velocity Time Integral (LVOT VTI) predict successful extubation?

What is the prognostic value of other echocardiographic measures such as Mitral Annular Plane Systolic Excursion (MAPSE), E/e' ratio, E/A ratio, Mitral Deceleration Time (MDT), and Myocardial Performance Index (Tei index) in forecasting weaning outcomes?

Participants will:

Be adults receiving mechanical ventilation and scheduled for weaning

Undergo transthoracic echocardiography (TTE) within 2 hours after meeting weaning criteria

Have the following parameters measured: LVOT VTI, MAPSE, E/e', E/A, MDT, and Tei index

Be monitored for 24 hours post-extubation to determine if they remain off ventilatory support, including reintubation, non-invasive ventilation, or high-flow oxygen therapy

This study aims to provide a comprehensive understanding of how systolic, diastolic, and global cardiac functions influence extubation success, potentially improving ICU decision-making and reducing complications, length of stay, and healthcare costs.

Eligibility criteria

Qualifiers

Currently receiving mechanical ventilation in the ICU

Planned extubation after meeting standard weaning criteria

Hemodynamically stable at the time of echocardiographic evaluation

Written informed consent obtained from the patient or legally authorized representative

Disqualifiers

Surgery within the previous 24 hours

Presence of significant valvular heart disease or known cardiomyopathy

Inadequate acoustic window for transthoracic echocardiography

Ongoing use of extracorporeal support (e.g., ECMO)

Trial design

Treatments tested in this trial

  • Echocardiographic Assessment

Treatment groups

50 Participants
are divided into 1 treatment group